Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges (Q38850538)

7 September 2017

1 reference

title

Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges (English)

1 reference

7 September 2017

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Heidrun Steinle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Andreas Behring

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Christian Schlensak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Hans Peter Wendel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

2 June 2016

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

68-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

Cystic Fibrosis Gene Therapy in the UK and Elsewhere

7 June 2020

cites work

1 reference

Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.

21 January 2018

1 reference

Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

21 January 2018

1 reference

Dendritic cell based vaccines for HIV infection: the way ahead

21 January 2018

1 reference

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

21 January 2018

1 reference

Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo

21 January 2018

1 reference

mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation.

21 January 2018

1 reference

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

21 January 2018

1 reference

Induced pluripotent stem cells generated without viral integration

21 January 2018

1 reference

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

21 January 2018

1 reference

Efficient generation of human iPSCs by a synthetic self-replicative RNA.

21 January 2018

1 reference

Assessing iPSC reprogramming methods for their suitability in translational medicine

21 January 2018

1 reference

Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.

21 January 2018

1 reference

Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin

21 January 2018

1 reference

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

Immunogenicity of induced pluripotent stem cells

21 January 2018

1 reference

All roads lead to induced pluripotent stem cells: the technologies of iPSC generation.

21 January 2018

1 reference

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

21 January 2018

1 reference

Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach

21 January 2018

1 reference

A comparison of non-integrating reprogramming methods

21 January 2018

1 reference

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

21 January 2018

1 reference

Particle size and activation threshold: a new dimension of danger signaling

21 January 2018

1 reference

Vectorology and factor delivery in induced pluripotent stem cell reprogramming.

21 January 2018

1 reference

RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

21 January 2018

1 reference

mRNA-based therapeutics--developing a new class of drugs

21 January 2018

1 reference

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.

21 January 2018

1 reference

Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability

21 January 2018

1 reference

Transfection of cultured eukaryotic cells using cationic lipid reagents

21 January 2018

1 reference

Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway.

21 January 2018

1 reference

Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition

21 January 2018

1 reference

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

mRNA is an endogenous ligand for Toll-like receptor 3.

21 January 2018

1 reference

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides

21 January 2018

1 reference

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis

21 January 2018

1 reference

Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus

21 January 2018

1 reference

5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I

21 January 2018

1 reference

Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates

21 January 2018

1 reference

Structural basis for m7G recognition and 2'-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I.

21 January 2018

1 reference

A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2'O-Methylated Self RNA.

21 January 2018

1 reference

Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5

21 January 2018

1 reference

Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.

21 January 2018

1 reference

Activation of MDA5 requires higher-order RNA structures generated during virus infection

21 January 2018

1 reference

Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA

21 January 2018

1 reference

Activation of innate immune antiviral responses by Nod2

21 January 2018

1 reference

Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger

21 January 2018

1 reference

Immune signaling by RIG-I-like receptors

21 January 2018

1 reference

Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells

21 January 2018

1 reference

Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner

21 January 2018

1 reference

Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins

21 January 2018

1 reference

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA

21 January 2018

1 reference

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

21 January 2018

1 reference

Synthetic mRNAs for manipulating cellular phenotypes: an overview

21 January 2018

1 reference

Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion.

21 January 2018

1 reference

Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy

21 January 2018

1 reference

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin

21 January 2018

1 reference

N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice

21 January 2018

1 reference

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

21 January 2018

1 reference

Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism

21 January 2018

1 reference

Cationic liposome-mediated RNA transfection

21 January 2018

1 reference

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

21 January 2018

1 reference

mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level

21 January 2018

1 reference

Synthetic mRNAs with superior translation and stability properties.

21 January 2018

1 reference

Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells

21 January 2018

1 reference

5'-Triphosphate RNA is the ligand for RIG-I

21 January 2018

1 reference

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

21 January 2018

1 reference

The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts

21 January 2018

1 reference

Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines

21 January 2018

1 reference

Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression.

21 January 2018

1 reference

Embryonic stem cell trials for macular degeneration: a preliminary report

21 January 2018

1 reference

Cell therapy for macular degeneration--first phase I/II pluripotent stem cell-based clinical trial shows promise.

21 January 2018

1 reference

Japan stem-cell trial stirs envy

21 January 2018

1 reference

Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration

21 January 2018

1 reference

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

21 January 2018

1 reference

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

21 January 2018

1 reference

Feeder-free derivation of human induced pluripotent stem cells with messenger RNA

21 January 2018

1 reference

Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming.

21 January 2018

1 reference

Lineage conversion methodologies meet the reprogramming toolbox

21 January 2018

1 reference

Direct reprogramming of fibroblasts into myocytes to reverse fibrosis

21 January 2018

1 reference

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

21 January 2018

1 reference

Direct conversion of human fibroblasts to multilineage blood progenitors.

21 January 2018

1 reference

In vivo reprogramming of adult pancreatic exocrine cells to beta-cells

21 January 2018

1 reference

Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors.

21 January 2018

1 reference

Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs

21 January 2018

1 reference

Direct conversion of fibroblasts to functional neurons by defined factors

21 January 2018

1 reference

Self-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression

21 January 2018

1 reference

The basic principles of chimeric antigen receptor design

21 January 2018

1 reference

Treatment of advanced leukemia in mice with mRNA engineered T cells

21 January 2018

1 reference

Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.

21 January 2018

1 reference

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia

21 January 2018

1 reference

In Vitro Evaluation of a Novel mRNA-Based Therapeutic Strategy for the Treatment of Patients Suffering from Alpha-1-Antitrypsin Deficiency.

21 January 2018

1 reference

Developing mRNA-vaccine technologies

21 January 2018

1 reference

mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer

21 January 2018

1 reference

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

21 January 2018

1 reference

Internal ribosome entry sites in eukaryotic mRNA molecules

21 January 2018

1 reference

Use of the viral 2A peptide for bicistronic expression in transgenic mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/STEM.2402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27250673%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference